Posted on 6/20/16
Social & Scientific Systems Appoints Dr. Paul Gorrell as Group VP
Social & Scientific Systems, Inc. (SSS), a public health research company, is pleased to announce the appointment of Paul Gorrell, PhD
Posted on 6/17/16
Better Buy: Intrexon Corporation vs. Inovio Pharmaceuticals Inc.
DNA. IMAGE SOURCE: GETTY IMAGES.Using DNA-based technology to battle Zika virus? That's what two companies are doing -- but in very different ways. Intrexon's (NYSE:XON) approach . . .
Posted on 6/17/16
Merck & Co., Inc. Wins This Round of the Immunotherapy Lung-Cancer Battle
IMAGE SOURCE: MERCK.Merck (NYSE:MRK) looks like it will win the race to have the first immunotherapy drug to gain Food and Drug Administration approval to treat . . .
Posted on 6/17/16
Visa Joins the Alliance for Safe Online Pharmacies
WASHINGTON--(BUSINESS WIRE)--Visa Inc. (NYSE:V) is now a member of the Alliance for Safe Online Pharmacies(ASOP Global), it was announced today by ASOP Global’s Executive Director, Libby . . .
Posted on 6/17/16
AAC Holdings Commences Development of 150-Bed Treatment Center in New Jersey
BRENTWOOD, Tenn. & RINGWOOD, N.J.--(BUSINESS WIRE)--AAC Holdings, Inc. (NYSE: AAC) announced that it has commenced development of a 150-bed residential treatment center at the site of . . .
Posted on 6/17/16
Kinney Drugs and HealtheConnections Partner
Kinney Drugs, a leading healthcare organization in New Yorkand Vermont, announced a collaborative healthcare partnership with HealtheConnections, a Syracuse-based regional health information organization (RHIO) supporting eleven . . .
Posted on 6/17/16
Amneal Pharmaceuticals Honored with Best Overall Generics Manufacturer Award by Healthcare Distribution Alliance
BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals today announced the company was recently honored with the Distribution Industry Award for Notable Achievements in Healthcare (DIANA) for Generic Pharmaceutical Product . . .
Posted on 6/17/16
Takeda and M2Gen Collaborate with ORIEN
Takeda Pharmaceutical Company Limited (TSE: 4502) and M2Gen®, a healthcare informatics solutions company, have established a new collaboration to generate broad genomic data from consenting cancer . . .
Posted on 6/17/16
Pfizer Breaks Ground On New Biologics Clinical Manufacturing Facility In Andover, Massachusetts
ANDOVER, Mass.--(BUSINESS WIRE)--Pfizer Inc. today broke ground for its new biologics clinical manufacturing facility in Andover, Massachusetts. Expanding the company’s presence in the state, Pfizer will . . .
Posted on 6/17/16
GlycoMimetics Proposes Stock Offering
ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (NASDAQ: GLYC), a clinical stage biotechnology company focused on the discovery and development of novel glycomimetic drugs, today announced that it intends . . .
Posted on 6/16/16
Cyclacel Regains Compliance With Nasdaq Continued Listing Requirements
BERKELEY HEIGHTS, N.J., June 16, 2016 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP), a biopharmaceutical company developing oral therapies that target the various phases of . . .
Posted on 6/16/16
TransPerfect Raises Over $300,000 for The V Foundation for Cancer Research
NEW YORK, June 16, 2016 (GLOBE NEWSWIRE) -- TransPerfect, the world’s largest privately held provider of language and technology solutions for global business, today announced that . . .
Posted on 6/17/16
NORD Appoints Marshall L. Summar, MD, as Chairman of the Board
The National Organization for Rare Disorders (NORD), the leading, independent advocacy organization committed
Posted on 6/16/16
Better Buy: Johnson & Johnson vs. Eli Lilly
IMAGE SOURCE: GETTY IMAGES.Pharmaceutical stocks have been hammered over the past year, leaving potential buyers with a plethora of potential bargains. At Johnson & Johnson (NYSE:JNJ), . . .
Posted on 6/16/16
Tonix Pharmaceuticals Announces Proposed Public Offering of Common Stock
NEW YORK, June 15, 2016 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp.(NASDAQ:TNXP) (Tonix), today announced that it intends to offer shares of its common stock in . . .
Posted on 6/16/16
Champions Oncology Closes Stock Offering
Champions Oncology, Inc. (NASDAQ: CSBR) a company engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology . . .
Posted on 6/16/16
Celgene Announces Additional $3 Billion Share Repurchase Authorization
SUMMIT, N.J.--(BUSINESS WIRE)--Celgene Corporation (NASDAQ:CELG) today announced that during its June meeting the Company's Board of Directors authorized the repurchase of up to an additional $3.0 . . .
Posted on 6/16/16
ImmunoGen Prices $100 Million Notes Offering
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (NASDAQ: IMGN) today announced the pricing of $100 million aggregate principal amount of its 4.50% convertible senior notes due 2021 in a . . .
Posted on 6/15/16
Immune Therapeutics Announces Engagement of Maxim Group to Provide Strategic Advisory Services
ORLANDO, Fla., June 15, 2016 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTCQB:IMUN), a clinical-stage biotech company providing immunotherapy solutions for the treatment of infectious and non-infectious . . .
Posted on 6/15/16
ProEx Physical Therapy Opens 15th New England Clinic in Arlington, MA
ProEx, a physical therapist owned private practice specializing in orthopedics, spine and sports medicine announces the opening of their 15th New England clinic located at 11 . . .
Posted on 6/15/16
Why ImmunoGen, Inc. Noted a Lower Price Today
IMAGE SOURCE: GETTY IMAGES.What: ImmunoGen (NASDAQ:IMGN) is down 18% at 1:00 p.m. EDT after the biotech announced last night that it plans to raise $100 million . . .
Posted on 6/15/16
3 Biotech Stocks to Buy If the Market Crashes
Jun 14, 2016 at 4:20PM IMAGE SOURCE: GETTY IMAGES.Celgene Corp. (NASDAQ:CELG), Regeneron Pharmaceuticals (NASDAQ:REGN), andGilead Sciences (NASDAQ:GILD) aren't immune to broader market pops and drops, but . . .
Posted on 6/15/16
Should Pfizer Buy This Beaten-Down Immuno-Oncology Company?
Bristol-Myers Squibb (NYSE: BMY) and Merck's(NYSE:MRK)game-changing(NYSE:MRK)immuno-oncology drugs, Opdivo and Keytruda, respectively, have triggered an avalanche of research into so-called "checkpoint inhibitors" due to their stunning commercial . . .
Posted on 6/15/16
Spark Therapeutics Announces Pricing of Public Offering
PHILADELPHIA, June 14, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics, Inc.(NASDAQ:ONCE) announced today the pricing of an underwritten public offering of 3,500,000 shares of its common stock . . .
